Open AccessOlmesartan medoxomil (OLM) reduces blood pressure (BP) load and improves goal rates more effectively than losartan potassium (LOS) and valsartan (VAL) in patients with essential hypertension
Author(s) -
J NEUTEL,
YiChung Lee,
T SILFANI
Publication year - 2005
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1016/j.amjhyper.2005.03.192
Subject(s) - medicine , valsartan , irbesartan , blood pressure , olmesartan , placebo , diastole , losartan , population , losartan potassium , cardiology , endocrinology , angiotensin ii , alternative medicine , environmental health , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom